MECP2 is a frequently amplified oncogene with a novel epigenetic mechanism that mimics the role of activated RAS in malignancy
- Manish Neupane
- , Allison P. Clark
- , Serena Landini
- , Nicolai J. Birkbak
- , Aron C. Eklund
- , Elgene Lim
- , Aedin C. Culhane
- , William T. Barry
- , Steven E. Schumacher
- , Rameen Beroukhim
- , Zoltan Szallasi
- , Marc Vidal
- , David E. Hill
- , Daniel P. Silver
- Dana-Farber Cancer Institute
- Harvard University
- Technical University of Denmark
- Garvan Institute of Medical Research
- Department of Molecular Biology
Research output: Contribution to journal › Article › peer-review